Bristol-Myers Seeks Buyer for Unit

Bristol-Myers Squibb Co. said it was seeking a buyer for a U.S. and Canadian consumer-products business that includes the Excedrin headache medicine and Keri moisturizers.

Prospective buyers will be contacted in coming weeks, the New York-based drug maker said.

Spokesman Brian Henry declined to name the organizations Bristol-Myers will approach and said negotiations hadn’t started.

The company hired Goldman Sachs Group Inc. to help with the sale, Henry said.

Shares of Bristol-Myers rose 6 cents to $24.66 on the New York Stock Exchange.